Скайризи
(Рисанкизумаб)
(150 mg)
(one)
(Шприц ручка)
Skyrizi ( risankizumab) 150 mg/ ml 1 syringe, Abbive, USA
Article:
In Stock
Risankizumab (brand name Skyrizi) is an interleukin-23 antagonist used to treat several immune-mediated inflammatory diseases. For detailed prescribing guidelines
-
Commercial name:Скайризи
-
Сhemical name:Рисанкизумаб
-
Dosage:150 mg
-
Quantity:one
-
Release form:Шприц ручка
-
Виробник:Abbive
No reviews yet